Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | PSEN1 | P49768 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | PRKCA | P17252 | 4/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11442064 | 1.00 | CYP1A2 (0.49) | CYP1A2CYP3A4TSHRPTGS1PTGS2 | |
| SCHEMBL11451306 | 0.83 | ALDH1A1 (0.41) | CYP1A2CYP3A4TSHRPTGS1PTGS2 | |
| SCHEMBL353005 | 0.81 | ALDH1A1 (0.40) | CYP1A2CYP3A4TSHRPTGS1PTGS2 | |
| SCHEMBL11524479 | 0.79 | ALDH1A1 (0.40) | CYP1A2CYP3A4TSHRPTGS1PTGS2 | |
| SCHEMBL24591296 | 0.74 | ALDH1A1 (0.39) | CYP1A2CYP3A4TSHRALDH1A1KDM4E | |
| SCHEMBL23252314 | 0.71 | LMNA (0.41) | TSHRLMNAPRKCA | |
| SCHEMBL15106146 | 0.71 | PTGS1 (0.39) | CYP1A2CYP3A4TSHRPTGS1PTGS2 | |
| SCHEMBL11524516 | 0.70 | CES2 (0.37) | CYP1A2CYP3A4ALDH1A1KDM4EMAPT | |
| SCHEMBL166075 | 0.70 | — | — | |
| SCHEMBL13933085 | 0.70 | PTGS1 (0.79) | CYP1A2CYP3A4TSHRPTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101198745-A | A process for organosolv pulping and use of a gamma lactone in a solvent for organosolv pulping | SHELL INT RESEARCH (NL) | 2008-06-11 | — | — | CN | claimed |
| EP-1891263-A1 | A PROCESS FOR ORGANOSOLV PULPING AND USE OF A GAMMA LACTONE IN A SOLVENT FOR ORGANOSOLV PULPING | Shell Internationale Research Maatschappij B.V. (NL) | 2008-02-27 | — | — | EP | claimed |
| US-20070100162-A1 | Process for the liquefaction of lignocellulosic material | SHELL OIL COMPANY | 2007-05-03 | — | — | US | claimed |
| US-20070034345-A1 | PROCESS FOR ORGANOSOLV PULPING AND USE OF A GAMMA LACTONE IN A SOLVENT FOR ORGANOSOLV PULPING | SHELL OIL COMPANY | 2007-02-15 | — | — | US | claimed |
| CN-1894230-A | Process for liquefying lignocellulosic material | SHELL INT RESEARCH (NL) | 2007-01-10 | — | — | CN | claimed |
| WO-2006134126-A1 | A PROCESS FOR ORGANOSOLV PULPING AND USE OF A GAMMA LACTONE IN A SOLVENT FOR ORGANOSOLV PULPING | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2006-12-21 | — | — | WO | claimed |
| EP-1699771-A1 | A PROCESS FOR THE LIQUEFACTION OF LIGNOCELLULOSIC MATERIAL | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 2006-09-13 | — | — | EP | claimed |
| WO-2005058856-A1 | A PROCESS FOR THE LIQUEFACTION OF LIGNOCELLULOSIC MATERIAL | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2005-06-30 | — | — | WO | claimed |
| US-3998875-A | PROCESS OF PREPARING 5-FLUORO-2-METHYL-1-(PARAMETHYLSULFINYLBENZYLIDENE)-INDENYL-3-ACETIC ACID | MERCK & CO., INC. (US) | 1976-12-21 | — | — | US | claimed |
| WO-2025099042-A1 | ORGANOMETALLIC SN OXO CARBOXYLATE CLUSTERS WITH CARBOXYLATE LIGANDS THAT CONTAIN A LINEAR OR CYCLIC ESTER FUNCTIONALITY | MERCK PATENT GMBH (DE) | 2025-05-15 | — | — | WO | disclosed |
| CN-101198745-A | A process for organosolv pulping and use of a gamma lactone in a solvent for organosolv pulping | SHELL INT RESEARCH (NL) | 2008-06-11 | — | — | CN | disclosed |
| EP-1891263-A1 | A PROCESS FOR ORGANOSOLV PULPING AND USE OF A GAMMA LACTONE IN A SOLVENT FOR ORGANOSOLV PULPING | Shell Internationale Research Maatschappij B.V. (NL) | 2008-02-27 | — | — | EP | disclosed |
| US-20070100162-A1 | Process for the liquefaction of lignocellulosic material | SHELL OIL COMPANY | 2007-05-03 | — | — | US | disclosed |
| US-20070034345-A1 | PROCESS FOR ORGANOSOLV PULPING AND USE OF A GAMMA LACTONE IN A SOLVENT FOR ORGANOSOLV PULPING | SHELL OIL COMPANY | 2007-02-15 | — | — | US | disclosed |
| US-4151177-A | Synthesis of optically active vitamin E | HOFFMANN-LA ROCHE INC. (US) | 1979-04-24 | — | — | US | disclosed |
| US-4151177-A | Synthesis of optically active vitamin E | HOFFMANN-LA ROCHE INC. (US) | 1979-04-24 | — | — | US | disclosed |
| US-4123457-A | 2-Methyl-5-fluoro-indanol-3-acetic acid | MERCK & CO., INC. (US) | 1978-10-31 | — | — | US | disclosed |
| US-4113740-A | Synthesis of optically active vitamin E | HOFFMANN-LA ROCHE INC. (US) | 1978-09-12 | — | — | US | disclosed |
| US-4113740-A | Synthesis of optically active vitamin E | HOFFMANN-LA ROCHE INC. (US) | 1978-09-12 | — | — | US | disclosed |
| US-3998875-A | PROCESS OF PREPARING 5-FLUORO-2-METHYL-1-(PARAMETHYLSULFINYLBENZYLIDENE)-INDENYL-3-ACETIC ACID | MERCK & CO., INC. (US) | 1976-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070100162-A1 | Process for the liquefaction of lignocellulosic material | ADH1C, DCXR, ADH1A | CYP1A2 163/4885CYP3A4 241/4885TSHR 3963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.